Oxidative Stress and Frailty: A Closer Look at the Origin of a Human Aging Phenotype

Aging: Oxidative Stress and Dietary Antioxidants

Volumn , Issue , 2014, Pages 3-14

  Wu, I Chien ^a   Hsiung, Chao A ^a   Hsu, Chih Cheng ^a   Lin, Xi Zhang ^b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Aged; Aging physiology; Cell aging physiology; Cell cycle; DNA damage; Frail elderly; Mitochondria; Oxidants physiology; Oxidative stress; Signal transduction

Indexed keywords

EID: 84903022887     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405933-7.00001-9     Document Type: Chapter

References (69)

1. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997, 82(2):291-295.
2. Masoro E.J., Austad S.N. Handbook of the biology of aging 2006, Academic Press, New York. 6th ed.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11(3):298-300.
4. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443(7113):787-795.
5. Fabrizio P., Liou L.L., Moy V.N., et al. SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics 2003, 163(1):35-46.
6. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120(4):449-460.
7. Migliaccio E., Giorgio M., Mele S., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402(6759):309-313.
8. Stadtman E.R. Protein oxidation and aging. Science 1992, 257(5074):1220-1224.
9. Soerensen M., Christensen K., Stevnsner T., Christiansen L. The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Mech Ageing Dev 2009, 130(5):308-314.
10. Khabour O.F., Abdelhalim E.S., Abu-Wardeh A. Association between SOD2 T-9C and MTHFR C677T polymorphisms and longevity: a study in a Jordanian population. BMC Geriatr 2009, 9:57.
11. Walston J., Hadley E.C., Ferrucci L., et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006, 54(6):991-1001.
12. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56(3):M146-156.
13. Barzilay J.I., Blaum C., Moore T., et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007, 167(7):635-641.
14. Mitnitski A.B., Mogilner A.J., Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J 2001, 1:323-336.
15. Mitnitski A., Song X., Skoog I., et al. Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 2005, 53(12):2184-2189.
16. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998, 279(8):585-592.
17. Morley J.E. Sarcopenia: diagnosis and treatment. J Nutr Health Aging 2008, 12(7):452-456.
18. Delmonico M.J., Harris T.B., Lee J.S., et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007, 55(5):769-774.
19. Goodpaster B.H., Carlson C.L., Visser M., et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 2001, 90(6):2157-2165.
20. Hughes V.A., Frontera W.R., Roubenoff R., et al. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 2002, 76(2):473-481.
21. Hubbard R.E., Lang I.A., Llewellyn D.J., Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci 2010, 65(4):377-381.
22. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11(2):85-97.
23. Ferrucci L., Corsi A., Lauretani F., et al. The origins of age-related proinflammatory state. Blood 2005, 105(6):2294-2299.
24. Mourkioti F., Kratsios P., Luedde T., et al. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest 2006, 116(11):2945-2954.
25. Ferrucci L., Penninx B.W., Volpato S., et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002, 50(12):1947-1954.
26. Greiwe J.S., Cheng B., Rubin D.C., et al. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 2001, 15(2):475-482.
27. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002, 87(2):589-598.
28. Bhasin S. Testicular disorders. Williams textbook of endocrinology 2008, 645-699. Saudners, Philadelphia. 11th ed. H.M. Kronenberg, S. Melmed, K.S. Polonsky, P.R. Larsen (Eds.).
29. Wu I.C., Lin X.Z., Liu P.F., et al. Low serum testosterone and frailty in older men and women. Maturitas 2010, 67(4):348-352.
30. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr Rev 1993, 14(1):20-39.
31. Cappola A.R., Bandeen-Roche K., Wand G.S., et al. Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 2001, 86(9):4139-4146.
32. Herbert J. The age of dehydroepiandrosterone. Lancet 1995, 345(8959):1193-1194.
33. Voznesensky M., Walsh S., Dauser D., et al. The association between dehydroepiandosterone and frailty in older men and women. Age Ageing 2009, 38(4):401-406.
34. Seals D.R., Esler M.D. Human ageing and the sympathoadrenal system. J Physiol 2000, 528(Pt 3):407-417.
35. Varadhan R., Chaves P.H., Lipsitz L.A., et al. Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices. J Gerontol A Biol Sci Med Sci 2009, 64(6):682-687.
36. Howard C., Ferrucci L., Sun K., et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol 2007, 103(1):17-20.
37. Semba R.D., Ferrucci L., Sun K., et al. Oxidative stress and severe walking disability among older women. Am J Med 2007, 120(12):1084-1089.
38. Fam S.S., Morrow J.D. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 2003, 10(17):1723-1740.
39. Cesari M., Kritchevsky S.B., Nicklas B., et al. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health, aging, and body composition study. J Gerontol A Biol Sci Med Sci 2012, 67(6):671-676.
40. Cesari M., Kritchevsky S.B., Nicklas B.J., et al. Lipoprotein peroxidation and mobility limitation: results from the Health, Aging, and Body Composition Study. Arch Intern Med 2005, 165(18):2148-2154.
41. Serviddio G., Romano A.D., Greco A., et al. Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress. Int J Immunopathol Pharmacol 2009, 22(3):819-827.
42. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003, 17(10):1195-1214.
43. Wu I.C., Shiesh S.C., Kuo P.H., Lin X.Z. High oxidative stress is correlated with frailty in elderly Chinese. J Am American Geriatr Soc 2009, 57(9):1666-1671.
44. Villamena F.A., Zweier J.L. Detection of reactive oxygen and nitrogen species by EPR spin trapping. Antioxid Redox Signal 2004, 6(3):619-629.
45. Baptista G., Dupuy A.M., Jaussent A., et al. Low-grade chronic inflammation and superoxide anion production by NADPH oxidase are the main determinants of physical frailty in older adults. Free Radic Res 2012, 46(9):1108-1114.
46. Li Y., Huang T.T., Carlson E.J., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995, 11(4):376-381.
47. Williams M.D., Van Remmen H., Conrad C.C., et al. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 1998, 273(43):28510-28515.
48. Petersen K.F., Dufour S., Befroy D., et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350(7):664-671.
49. Trifunovic A., Wredenberg A., Falkenberg M., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429(6990):417-423.
50. Matalon S., Hardiman K.M., Jain L., et al. Regulation of ion channel structure and function by reactive oxygen-nitrogen species. Am J Physiol Lung Cell Mol Physiol 2003, 285(6):L1184-1189.
51. Du J., Wang X., Miereles C., et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004, 113(1):115-123.
52. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357(Pt 3):593-615.
53. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002, 192(1):1-15.
54. Lebovitz R.M., Zhang H., Vogel H., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996, 93(18):9782-9787.
55. Muller F.L., Song W., Liu Y., et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med 2006, 40(11):1993-2004.
56. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007, 8(9):729-740.
57. Krishnamurthy J., Ramsey M.R., Ligon K.L., et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006, 443(7110):453-457.
58. Molofsky A.V., Slutsky S.G., Joseph N.M., et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006, 443(7110):448-452.
59. Minamino T., Orimo M., Shimizu I., et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009, 15(9):1082-1087.
60. Tyner S.D., Venkatachalam S., Choi J., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415(6867):45-53.
61. Yu C.E., Oshima J., Fu Y.H., et al. Positional cloning of the Werner's syndrome gene. Science 1996, 272(5259):258-262.
62. Chang S., Multani A.S., Cabrera N.G., et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004, 36(8):877-882.
63. Lombard D.B., Beard C., Johnson B., et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 2000, 20(9):3286-3291.
64. Baker D.J., Wijshake T., Tchkonia T., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479(7372):232-236.
65. Baker D.J., Jeganathan K.B., Cameron J.D., et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 2004, 36(7):744-749.
66. D'Autreaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007, 8(10):813-824.
67. Kaneto H., Nakatani Y., Miyatsuka T., et al. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med 2004, 10(10):1128-1132.
68. Finkel T. Redox-dependent signal transduction. FEBS Lett 2000, 476(1-2):52-54.
69. Haddad J.J. Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics. Free Radic Biol Med 2002, 33(7):907-926.